Suma Krishnan Krystal Biotech, Inc. (KRYS) insider trading activity

KRYS Quotes by TradingView

Suma Krishnan is President, R&D of Krystal Biotech, Inc.. Currently has a direct ownership of 1.48 Million shares of KRYS, which is worth approximately $237 Million. The most recent transaction as insider was on Dec 13, 2024, when has been sold 25,000 shares (Common Stock) at a price of $167.16 per share, resulting in proceeds of $4,179,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.48M
1.67% 3M change
6.25% 12M change
Total Value Held $237 Million

Suma Krishnan Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 13 2024
SELL
Open market or private sale
$4,179,000 $167.16 p/Share
25,000 Reduced 1.67%
1,475,882 Common Stock
Sep 12 2024
SELL
Open market or private sale
$4,959,500 $198.38 p/Share
25,000 Reduced 1.64%
1,500,882 Common Stock
Jun 11 2024
SELL
Open market or private sale
$4,371,250 $174.85 p/Share
25,000 Reduced 1.61%
1,525,882 Common Stock
Mar 11 2024
SELL
Open market or private sale
$4,279,500 $171.18 p/Share
25,000 Reduced 1.59%
1,550,882 Common Stock
Feb 28 2024
SELL
Payment of exercise price or tax liability
$566,050 $163.08 p/Share
3,471 Reduced 0.22%
1,575,882 Common Stock
Feb 28 2024
BUY
Exercise of conversion of derivative security
-
7,500 Added 0.47%
1,579,353 Common Stock
Feb 26 2024
SELL
Payment of exercise price or tax liability
$369,421 $157.0 p/Share
2,353 Reduced 0.15%
1,571,853 Common Stock
Dec 11 2023
SELL
Open market or private sale
$2,644,000 $105.76 p/Share
25,000 Reduced 1.56%
1,574,206 Common Stock
Sep 11 2023
SELL
Open market or private sale
$3,180,250 $127.21 p/Share
25,000 Reduced 1.54%
1,599,206 Common Stock
May 31 2023
SELL
Open market or private sale
$2,920,000 $116.8 p/Share
25,000 Reduced 1.52%
1,624,206 Common Stock
Apr 17 2023
SELL
Open market or private sale
$2,186,500 $87.46 p/Share
25,000 Reduced 1.49%
1,649,206 Common Stock
Feb 26 2023
SELL
Payment of exercise price or tax liability
$239,852 $78.46 p/Share
3,057 Reduced 0.18%
1,674,206 Common Stock
Jan 18 2023
SELL
Open market or private sale
$231,439 $81.15 p/Share
2,852 Reduced 0.17%
1,677,263 Common Stock
Jan 17 2023
SELL
Open market or private sale
$1,807,498 $81.61 p/Share
22,148 Reduced 1.3%
1,680,115 Common Stock
Jan 04 2023
SELL
Open market or private sale
$315,394 $80.09 p/Share
3,938 Reduced 0.23%
1,702,263 Common Stock
Jan 03 2023
SELL
Open market or private sale
$136,561 $80.33 p/Share
1,700 Reduced 0.1%
1,706,201 Common Stock
Dec 29 2022
SELL
Open market or private sale
$646,568 $80.7 p/Share
8,012 Reduced 0.47%
1,707,901 Common Stock
Dec 16 2022
SELL
Open market or private sale
$843,212 $80.1 p/Share
10,527 Reduced 0.61%
1,715,913 Common Stock
Nov 08 2022
SELL
Open market or private sale
$65,872 $80.04 p/Share
823 Reduced 0.05%
1,726,440 Common Stock
Aug 05 2022
SELL
Open market or private sale
$2,033,750 $81.35 p/Share
25,000 Reduced 1.43%
1,727,263 Common Stock
Feb 26 2022
SELL
Payment of exercise price or tax liability
$205,125 $62.5 p/Share
3,282 Reduced 0.19%
1,752,263 Common Stock
Feb 26 2021
BUY
Grant, award, or other acquisition
-
28,400 Added 1.5%
1,864,464 Common Stock
SK

Suma Krishnan

President, R&D
Pittsburgh, PA

Track Institutional and Insider Activities on KRYS

Follow Krystal Biotech, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRYS shares.

Notify only if

Insider Trading

Get notified when an Krystal Biotech, Inc. insider buys or sells KRYS shares.

Notify only if

News

Receive news related to Krystal Biotech, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on KRYS